resection for breast cancer or carcinoma in situ, followed by breast reconstruction, from 2010 to 2015. 524 patients met inclusion criteria: 148 (28.2%) patients underwent AFG (test group), while 376 (71.7%) patients did not undergo AFG (control group). Patient demographics, cancer characteristics, oncologic treatment, surgical treatment, surgical complications, local recurrence, and distant metastases were analyzed.
Mean follow-up time from initial surgery was 42.1 months in the AFG group and 34.5 months in the control group (p<0.01). The overall complication rate following AFG was 9.4%; with a 1.7% infection rate, 1.3% fat necrosis rate, 6.0% oil cyst rate, and 0.4% wound healing problem rate. There were no incidences of seroma or hematoma following AFG. Additionally, the AFG and non-AFG groups demonstrated no significant differences in overall reconstructive complication rates (25.2% vs. 23.5%), or individual rates of infection, wound healing complications, hematoma or seroma formation, implant exposure, or flap failure. Among breasts receiving surgery for therapeutic indications (AFG n=162, control n=414), there were similar rates of local recurrence: AFG group 2.5%, control group 1.9% (p=0.688). Interestingly, the mean time to recurrence was significantly longer in the AFG group (52.3 vs. 22.8 months from initial surgery, p=0.02).
CONCLUSION:
AFG is a powerful tool in breast reconstruction. This large single-institution study, which evaluates patients of comparable BRCA status, cancer staging, chemotherapy, and radiation therapy, provides valuable evidence-based support for its oncologic safety. PURPOSE: Some developments in the evolution of perforator flaps in autologous breast reconstruction include attempts to reinnervate the harvested tissue. There is a paucity of data on sensory reinnervation but it has been reported that the use of innervated autologous flaps in breast reconstruction can provide stability, protection from direct trauma, recovery of erogenous sensation and higher patient satisfaction.
Disclosure
1,2,3 Previous studies have evaluated the anterior abdominal wall intercostal nerve anatomy as a donor nerve to be raised with autologous abdominal based flaps.
3 This study provides the anatomical basis to determine the optimum recipient site choice for sensory coaptation in microsurgical breast reconstruction.
METhOdS:
Twelve hemi-chests were dissected from six fresh (non-frozen) cadaveric females, with a median age of 79 years (range 63-100) and BMI of 26.8.Dissections were carried out from the anterior midline proceeding laterally to identify subcutaneous portions of cutaneous branches of the anterior cutaneous intercostal nerve and then exposure of the first six ribs. Costal cartilage was sequentially removed to expose the internal mammary vessels and the anterior cutaneous intercostal nerve (ACB) and the lateral (subcutaneous) branch of the anterior cutaneous intercostal nerve (LACB). Anatomical measurements were recorded and nerve samples from both branches were reviewed histologically. Specimens were cross-sectioned and stained with H&E and Karnovsky and Roots Staining to differentiate sensory fascicles. 4 RESULTS: A lateral subcutaneous branch of the anterior cutaneous branch of the intercostal nerve (LACB) was noted consistently in the 2nd to 4th rib space (96% cases), with a median length of 43mm, 37.5mm and 37mm respectively. These nerves perforated the intercostal muscles within 1cm from the sternal edge, and the length and diameter of the LACB diminished caudally, with the largest diameter nerves at the 2nd-4th intercostal spaces. Histological analysis demonstrated that the LACB nerves had consistently a greater average total fascicular area than ACB nerves (18513um2 PSTM Abstract Supplement
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versus 5420um2). In addition, LACB nerves had a larger area per fascicle than the ACB nerves (6784um2 versus 5420um2), demonstrating differences in individual fascicle size between LACB and ACB nerves.
CONCLUSIONS:
A better understanding of characteristics of the anterior cutaneous intercostal nerve branches can optimize the site of recipient site coaptation. On preparation of the internal mammary vessels, preservation of the LACB can provide better size, with good sensory innervation for coaptation. 
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METhOdS:
A retrospective review of patients undergoing microsurgical breast reconstruction using the internal mammary vessels as recipient vessels was conducted from March 2000 to December 2014. Patient demographics, tumor characteristics, preoperative lymph node mapping, reconstructive timing and outcomes were studied.
RESULTS:
A total of 524 microsurgical breast reconstructions in 516 patients were performed using the internal mammary vessels. IMLNs were sampled in 53 immediate and 42 delayed breast reconstructions. Eight (seven in the immediate and one in the delayed group) of the sampled nodes were positive for cancer metastasis, for an incidence of 8.4% in identified lymph nodes. All patients with metastatic IMLNs subsequently received local-regional radiation and chemotherapy. All patients were alive, and 6 were disease-free at the conclusion of the study period, which had an average follow up of 67.3 months.
CONCLUSION: Visible IMLNs should be routinely sampled during recipient vessel preparation for microsurgical breast reconstruction. This series underscores the essential role of plastic surgeons in assisting with disease staging to provide adequate adjuvant treatment and improve the survival of breast cancer patients.
